Travere Therapeutics Inc’s filing revealed that its Officer Dube Eric M acquired Company’s shares for reported $0.24 million on Jan 23 ’26. In the deal valued at $30.01 per share,8,135 shares were bought.
Then, REED ELIZABETH E sold 10,000 shares, generating $273,420 in total proceeds. Upon selling the shares at $27.34, the Chief Legal Officer and GC now owns 90,270 shares.
Before that, ELIZABETH REED bought 10,000 shares. Travere Therapeutics Inc shares valued at $273,420 were divested by the Officer at a price of $27.34 per share.
Citigroup reiterated its Travere Therapeutics Inc [TVTX] rating to a Buy in a research note published on October 31, 2025; the price target was $48. Citigroup also remained covering TVTX and reiterated its “Buy” recommendation on June 11, 2025. Cantor Fitzgerald started covering the stock on January 10, 2025. It rated TVTX as “an Overweight”.
Price Performance Review of TVTX
On Friday, Travere Therapeutics Inc [NASDAQ:TVTX] saw its stock fall -0.98% to $29.44. Over the last five days, the stock has gained 3.66%. Travere Therapeutics Inc shares have risen nearly 51.28% since the year began. Nevertheless, the stocks have fallen -22.95% over the past one year.
How much short interest is there in Travere Therapeutics Inc?
A steep rise in short interest was recorded in Travere Therapeutics Inc stocks on 2025-12-31, growing by 3.34 million shares to a total of 14.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 10.97 million shares. There was a rise of 23.36%, which implies that there is a positive sentiment for the stock.
